Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies

Emily B. Levitan, Yiqing Song, Earl S. Ford, Simin Liu

Research output: Contribution to journalArticle

446 Citations (Scopus)

Abstract

Background: Although hyperglycemia increases the risk of cardiovascular disease (CVD) in diabetic patients, the risk associated with blood glucose levels in the nondiabetic range remains unsettled. Mothods: We identified 38 reports in which CVD incidence or mortality was an end point, blood glucose levels were measured prospectively, and the relative risk (RR) and information necessary to calculate the variance were reported comparing groups of nondiabetic people. These reports were prospective studies, published in English-language journals. First author, publication year, participant age and sex, study duration, CVD end points, glucose assessment methods, control for confounding, range of blood glucose levels, RR, and confidence intervals (CIs) or P values were extracted. Using a random effects model, we calculated pooled RRs and 95% CIs. Results: The group with the highest postchallenge blood glucose level (midpoint range, 150-194 mg/dL [8.3-10.8 mmol/L]) had a 27% greater risk for CVD compared with the group with the lowest level (midpoint range, 69-107 mg/dL [3.8-5.9 mmol/L]) (RR, 1.27 [95% CI, 1.09-1.48]). The results were similar when combining studies regardless of type of blood glucose assessment (RR, 1.36 [95% CI, 1.23-1.52]) and when using strict criteria for exclusion of diabetic subjects (RR, 1.26 [95% CI, 1.11-1.43]). Adjustment for CVD risk factors attenuated but did not abolish this relationship (RR, 1.19 [95% CI, 1.07-1.32]). The RR was greater in cohorts including women than in cohorts of men (RR, 1.56 vs 1.24 [P=.03]). Conclusion: Blood glucose level is a risk marker for CVD among apparently healthy individuals without diabetes.

Original languageEnglish (US)
Pages (from-to)2147-2155
Number of pages9
JournalArchives of Internal Medicine
Volume164
Issue number19
DOIs
StatePublished - Oct 25 2004
Externally publishedYes

Fingerprint

Hyperglycemia
Meta-Analysis
Cardiovascular Diseases
Prospective Studies
Blood Glucose
Confidence Intervals
Publications
Language
Glucose
Mortality

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. / Levitan, Emily B.; Song, Yiqing; Ford, Earl S.; Liu, Simin.

In: Archives of Internal Medicine, Vol. 164, No. 19, 25.10.2004, p. 2147-2155.

Research output: Contribution to journalArticle

@article{345f82eb0b114dd9a2ae6f8df654ed16,
title = "Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies",
abstract = "Background: Although hyperglycemia increases the risk of cardiovascular disease (CVD) in diabetic patients, the risk associated with blood glucose levels in the nondiabetic range remains unsettled. Mothods: We identified 38 reports in which CVD incidence or mortality was an end point, blood glucose levels were measured prospectively, and the relative risk (RR) and information necessary to calculate the variance were reported comparing groups of nondiabetic people. These reports were prospective studies, published in English-language journals. First author, publication year, participant age and sex, study duration, CVD end points, glucose assessment methods, control for confounding, range of blood glucose levels, RR, and confidence intervals (CIs) or P values were extracted. Using a random effects model, we calculated pooled RRs and 95{\%} CIs. Results: The group with the highest postchallenge blood glucose level (midpoint range, 150-194 mg/dL [8.3-10.8 mmol/L]) had a 27{\%} greater risk for CVD compared with the group with the lowest level (midpoint range, 69-107 mg/dL [3.8-5.9 mmol/L]) (RR, 1.27 [95{\%} CI, 1.09-1.48]). The results were similar when combining studies regardless of type of blood glucose assessment (RR, 1.36 [95{\%} CI, 1.23-1.52]) and when using strict criteria for exclusion of diabetic subjects (RR, 1.26 [95{\%} CI, 1.11-1.43]). Adjustment for CVD risk factors attenuated but did not abolish this relationship (RR, 1.19 [95{\%} CI, 1.07-1.32]). The RR was greater in cohorts including women than in cohorts of men (RR, 1.56 vs 1.24 [P=.03]). Conclusion: Blood glucose level is a risk marker for CVD among apparently healthy individuals without diabetes.",
author = "Levitan, {Emily B.} and Yiqing Song and Ford, {Earl S.} and Simin Liu",
year = "2004",
month = "10",
day = "25",
doi = "10.1001/archinte.164.19.2147",
language = "English (US)",
volume = "164",
pages = "2147--2155",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "19",

}

TY - JOUR

T1 - Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies

AU - Levitan, Emily B.

AU - Song, Yiqing

AU - Ford, Earl S.

AU - Liu, Simin

PY - 2004/10/25

Y1 - 2004/10/25

N2 - Background: Although hyperglycemia increases the risk of cardiovascular disease (CVD) in diabetic patients, the risk associated with blood glucose levels in the nondiabetic range remains unsettled. Mothods: We identified 38 reports in which CVD incidence or mortality was an end point, blood glucose levels were measured prospectively, and the relative risk (RR) and information necessary to calculate the variance were reported comparing groups of nondiabetic people. These reports were prospective studies, published in English-language journals. First author, publication year, participant age and sex, study duration, CVD end points, glucose assessment methods, control for confounding, range of blood glucose levels, RR, and confidence intervals (CIs) or P values were extracted. Using a random effects model, we calculated pooled RRs and 95% CIs. Results: The group with the highest postchallenge blood glucose level (midpoint range, 150-194 mg/dL [8.3-10.8 mmol/L]) had a 27% greater risk for CVD compared with the group with the lowest level (midpoint range, 69-107 mg/dL [3.8-5.9 mmol/L]) (RR, 1.27 [95% CI, 1.09-1.48]). The results were similar when combining studies regardless of type of blood glucose assessment (RR, 1.36 [95% CI, 1.23-1.52]) and when using strict criteria for exclusion of diabetic subjects (RR, 1.26 [95% CI, 1.11-1.43]). Adjustment for CVD risk factors attenuated but did not abolish this relationship (RR, 1.19 [95% CI, 1.07-1.32]). The RR was greater in cohorts including women than in cohorts of men (RR, 1.56 vs 1.24 [P=.03]). Conclusion: Blood glucose level is a risk marker for CVD among apparently healthy individuals without diabetes.

AB - Background: Although hyperglycemia increases the risk of cardiovascular disease (CVD) in diabetic patients, the risk associated with blood glucose levels in the nondiabetic range remains unsettled. Mothods: We identified 38 reports in which CVD incidence or mortality was an end point, blood glucose levels were measured prospectively, and the relative risk (RR) and information necessary to calculate the variance were reported comparing groups of nondiabetic people. These reports were prospective studies, published in English-language journals. First author, publication year, participant age and sex, study duration, CVD end points, glucose assessment methods, control for confounding, range of blood glucose levels, RR, and confidence intervals (CIs) or P values were extracted. Using a random effects model, we calculated pooled RRs and 95% CIs. Results: The group with the highest postchallenge blood glucose level (midpoint range, 150-194 mg/dL [8.3-10.8 mmol/L]) had a 27% greater risk for CVD compared with the group with the lowest level (midpoint range, 69-107 mg/dL [3.8-5.9 mmol/L]) (RR, 1.27 [95% CI, 1.09-1.48]). The results were similar when combining studies regardless of type of blood glucose assessment (RR, 1.36 [95% CI, 1.23-1.52]) and when using strict criteria for exclusion of diabetic subjects (RR, 1.26 [95% CI, 1.11-1.43]). Adjustment for CVD risk factors attenuated but did not abolish this relationship (RR, 1.19 [95% CI, 1.07-1.32]). The RR was greater in cohorts including women than in cohorts of men (RR, 1.56 vs 1.24 [P=.03]). Conclusion: Blood glucose level is a risk marker for CVD among apparently healthy individuals without diabetes.

UR - http://www.scopus.com/inward/record.url?scp=6944253559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=6944253559&partnerID=8YFLogxK

U2 - 10.1001/archinte.164.19.2147

DO - 10.1001/archinte.164.19.2147

M3 - Article

C2 - 15505129

AN - SCOPUS:6944253559

VL - 164

SP - 2147

EP - 2155

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 19

ER -